Background-.Although nitric oxide (NO) has been found to have a role in gut inflammation and to modulate immunoglobulin production, little is known about its part in food hypersensitivities. Aim-This study aimed to evaluate the role of NO through the inhibition of constitutive and inducible NO synthase (cNOS and iNOS respectively) on the sensitisation process (antibody titres) and on intestinal anaphylactic responses (colonic hypersecretion upon antigen challenge). Animals and methods-Guinea pigs sensitised to cow's milk proteins were treated either during the sensitisation period or before antigen challenge by N-nitro-Larginine methyl ester (L-NAME) (inhibiting both cNOS and iNOS) or amino-guanidine (selective iNOS inhibitor). Results-Chronic treatment by L-NAME or aminoguanidine reduced antibody titres and the secretory response to antigen challenge. In contrast, only L-NAME administered before challenge was able to antagonise the hypersecretion induced by the challenge.
The production of nitric oxide (NO) has been shown in a great number of mammalian cells as diverse as endothelial cells,l neurons,2 intestinal mucosal,3 and immune cells. 4 This short lived molecule is produced from L-arginine by an enzyme, NO synthase. Two distinct types of NO synthase have been described, a constitutive Ca2+/calmodulin dependent enzyme (cNOS) and an inducible form (iNOS), Ca2+/calmodulin independent induced by cytokines or endotoxins.2 While cNOS is found in endothelial vascular cells, neurons, and intestinal cells, iNOS has been identified in a variety of immunocompetent cells including macrophages5 and neutrophils. 6 The role of NO in gut inflammation is evident but controversial: NO being either protective or deleterious depending on the nature of the insult, its duration (acute or chronic inflammation), and the enzymatic source of NO (cNOS or iNOS).7 Although there is increasing interest in the role of NO in gut inflammation, very few studies consider the part played by NO in food allergies. Nevertheless, these pathologies imply inflammatory mediator production and release involving NO generation.
This study was designed to evaluate the role of NO in the sensitisation process through chronic inhibition of cNOS and iNOS during the period of sensitisation in a model of cow's milk allergy in the guinea pig.8 Because NO synthase inhibition has been reported to increase intestinal permeability,9 which is an important factor for antigen uptake, this parameter was assessed during the sensitisation period. In addition, the role of NO in the anaphylactic response (intestinal hypersecretion) induced by antigen challenge in sensitised animals was also investigated.
Methods

ANIMAL -SENSITISATION
Thirty six male Dunkin-Hartley guinea pigs (250-300 g) divided into six groups were used for these experiments (Interfauna, Loches, France). A milk protein-free solid pellet diet was supplied to all animals. Animals were sensitised to cow's milk proteins by giving them only fresh pasteurised cow's milk to drink instead of water for four weeks.8 These animals were allowed to drink water five to six days before the day of antigen challenge. A group of six animals had water available instead of milk and was used as control.
ANTIBODY TITRES
Blood was drawn by cardiac puncture the day before antigen challenge to determine anti-a lactoglobulin antibody titres by passive cutaneous anaphylaxis (PCA) test. Briefly, 100 ,u of the diluted sera ranging from 1:2 to 1:256 were injected intradermally into the shaved flanks of naive guinea pigs. Two days later, 2-5 mg of 3 lactoglobulin in Evans' blue dye (1% in 9%o NaCl solution) were injected intravenously in a final volume of 0 5 ml. One hour later, PCA reactivity was measured as the highest dilution which yielded a positive response (local skin blueing with a diameter -4 mm).
Titres were expressed as the log of the highest dilution giving blue patches.
EVALUATION OF ANTIGEN INDUCED COLONIC SECRETION
Modification of water intestinal transport is a characteristic feature of intestinal anaphylaxis.°0 To assess the response to antigen challenge, we measured the net water flux of an isolated colonic loop.11 12 A midline laparotomy was performed in anaesthetised (urethane 2 g/kg intraperitoneally (ip)) guinea pigs to expose the large intestine. A 5 cm segment of proximal colon 3 cm from the caecocolonic junction was isolated and cannulated for intraluminal perfusion. After cleansing the contents, the loop was replaced in the abdominal cavity, which was then closed, and the colonic segment was infused with a Ringer's buffer solution containing 1 ,uCi/l of (14C) polyethylene glycol 4000 as a marker and 5 g/l of cold polyethylene glycol 4000 as a carrier. The loop was infused at a constant rate (6 ml/h) and the effluent was collected for 15 minute periods over 180 minutes. After an equilibration period (90 minutes), antigen challenge was performed by adding P lactoglobulin (100 mg) to the Ringer's solution. Antigen was infused for 30 minutes. 14C activity in collected samples was measured by liquid scintillation, and water flux for every 15 minute period was calculated using the following formula: Net water flux (rd/cm/h) = (1 -dpms/dpmx) XP/L where dpms and dpmx are the 14C activities in Ringer's solution and the effluent respectively; P is the perfusion rate (p1/h) and L the length (cm) of the colonic segment.
Water flux values measured over two consecutive 15 minute periods were averaged to obtain a mean net flux of water over a 30 minute period. Positive values represented net absorption of water and negative values, net secretion.
INTESTINAL PERMEABILITY
Intestinal permeability was determined in control animals (water) and milk-drinking guinea pigs chronically treated or not with NO synthase inhibitors. This evaluation was performed before milk diet and later on, every week during the four weeks of sensitisation.
To assess epithelial permeability 1 ml of the probe (51Cr-EDTA, 3 Similarly, aminoguanidine significantly (p=0.013) decreased antibody titres: mean 0.90 (0.63), range 0-1.5 (Fig 1) . The mean values corresponded to blue patches appearing at a mean serum dilution of 1:8 (treated animals) whereas in untreated ones the dilution was 1:64. After stopping P lactoglobulin challenge, the net water absorption was restored and values after infusion were not significantly different from basal values. In sensitised animals, treated chronically by L-NAME or aminoguanidine, the challenge induced hypersecretion was significantly (p<001) reduced: -9.5 (6.5) and -1-4 (3.3) respectively v -165.8 (62.5) iil/cm/h in untreated animals (Fig 3) .
Intestinal permeability Intestinal permeability in milk-drinking animals measured after one week of L-NAME or aminoguanidine treatment was significantly (p<0 05) higher than that in vehicle treated animals. Thereafter, the intestinal permeability (vehicle, L-NAME, aminoguanidine) but 3 lactoglobulin infusion significantly lower than the first week values for treated animals only (Fig 4) . (Fig 2) . We have shown that L-NAME and aminoguanidine are equally efficient at reducing the sensitisation rate. As L-NAME is a non-selective inhibitor of cNOS and iNOS and aminoguanidine is selective for iNOS, we suggest that NO production via iNOS is involved in the sensitisation process. iNOS has been reported to be induced after activation of different cells involved in immunological reactions by cytokines,2 and when expressed, this enzyme synthesises NO for a long period. This mode of induction fits well with our model in which antibody synthesis was cytokine dependent and the sensitisation process was time related as animals were subjected to antigen for four weeks. Furthermore, this result agrees with in vitro studies showing that there is a striking correlation between NO release and IgE production and that the accumulation of NO becomes significant after about five days of stimulation, suggesting that this process requires the induction of iNOS. 16 Intestinal permeability, which is involved in antigen penetration, was evaluated using 51Cr- The second part of our study showed that L-NAME, but not aminoguanidine, administered one hour before challenge reversed the hypersecretion triggered by P3 lactoglobulin infusion. This leads us to think that NO synthesis via cNOS plays a prominent role in the antigen induced hypersecretion. NO is widely distributed throughout the intestine, including smooth muscle'9 and inflammatory cells, neurons of myenteric plexus and epithelial cells. Moreover, NO is released from mast cells when activated20 and from vascular endothelial cells stimulated by inflammatory mediators2' produced by mast cell degranulation. We suggest that in our model, mast cell degranulation released either directly or indirectly (via inflammatory mediators) great quantities of NO which caused hypersecretion. However, it has been shown that L-NAME administration degranulates mast cells22 rendering them insensitive to further antigenic stimulation. This possibility can be ruled out because challenge administrations of L-NAME or aminoguanidine one hour beforehand, at the doses used in this study, did not change the basal net water flux. Furthermore, our hypothesis is supported by several other workers. On one hand, NO donors stimulated fluid accumulation,23 modulated electrolyte transport,24 and activated chloride secretion25 and on the other, L-NAME was able to reverse luminal fluid accumulation in guinea pig ileitis26 and to prevent diarrhoea caused by administration of castor oil,27 diphenylmethane laxatives,28 or bile salts29 in rats. Moreover, and in support of our findings, recent work from our laboratory has shown that IL-1 is involved in the anaphylactic colonic hypersecretion induced by antigen challenge in the sensitised guinea pig30 and that the I-1 induced hypersecretion can be blocked by a NOS inhibitor.3' Alternatively, it has been reported that L-NAME displays some antimuscarinic action,32 which can explain the blockade of antigen induced hypersecretion since cholinergic neurons are involved in this secretory response. However, at the dose used, L-NAME exerts in vivo a stimulation of gut motility hardly compatible with an antagonism on muscarinic receptors.
We conclude that NO may function as a common or a final mediator, or both, in this model of hypersecretion.
